Lopez, Shane Bensaint M.
HRN: 18-89-97 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/04/2024
CEFUROXIME 1.5GM (VIAL)
11/04/2024
11/11/2024
IV
1.5 Grams
Q8H
T/C Mild TB; Abrasions Sec To MVA
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes